Laboratory of Advanced Chemical Biology

Research Theme
Rational drug discovery based on a theory of dynamic epitope and innovative glycotechnology platform
Research Keywords

Chemical biology, Medicinal chemistry, Glycomedicine, Automated glycosynthesis, Glycomics, Glycobiology, Biomarker discovery, Dynamic epitope, Glycopeptide, Antibody drug, Glycoconjugates probe, Microarray


Overview of Research and Education

Research Contents: Toward personalized medicine, our goal is to establish a promising strategy for the rational drug discovery system from disease-relevant “dynamic epitopes” based on the specific posttranslational modification of the key glycoproteins. Our new glycotechnology platform, notably glycoblotting-based high throughput glycomics and microarray displaying robust synthetic glycopeptides library, allowed for the development of epitope-defined antibodies showing potent anti-cancer activities.
At the core of our focused library construction technology, we are continuing to innovate molecular-based life technology such as microarrays and absolute quantification technology of specific key structures in life.

Laboratory of Advanced Chemical Biology (pdf)



N21, W11, Kita-ku, Sapporo, Hokkdido
shin*  (Please replace * with @ when sending e-mail.)

Representative Publications

Wakui H., Tanaka Y., Ose T., Matsumoto I., Kato K., Yao M., Tachibana T., Sato M., Naruchi K., García-Martín F., Hinou H., Nishimura S-I. “A straightforward approach to antibodies recognising cancer specific glycopeptidic neoepitopes” Chem. Sci. in press

Hayakawa A., Matsushita T., Yokoi Y., Wakui H., Fayna Garcia-Martin, Hinou H., Matsuoka K., Nouso H., Kamiyama T., Taketomi A, Nishimura S-I. “Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes” Biochemistry 59, 1221-1241 (2020)

Koide R., Nishimura S-I., “Antiadhesive nanosomes facilitate targeting of lysosomal GlcNAc salvage pathway through derailed cancer endocytosis” Angew. Chem. Int. Ed. 58, 14513-14518 (2019)

Gebrehiwot Abrha G., Seifu Melka D., Mamo Kassaye Y., Rehan F.I., Rangappa S., Hinou H., Kamiyama T., Nishimura S-I., “Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers” PLOS ONE 12, e0209515 (2018)

Somovilla V.J., Bermeijo I.A., Albuquerque I.S., Martínez-S. N., Castro-Lopez J., Garcia-Martin F., Companon I.., Hinou H., Nishimura S-I., Jimenez-Barbero J., Asensio J.L, Avenoza G., Busto J.H., Hurtado-Guerrero. R., Peregrina J.M., Bernardes G.J.L., Corzana F., “The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies in patients with prostate cancer”, J. Am. Chem. Soc. 129, 18255-18261 (2017)

Ohyabu N, Kakiya K., Yokoi Y., Hinou H., Nishimura S-I., “Convergent solid-phase synthesis of macromolecular MUC1 models truly mimicking serum glycoprotein biomarkers of interstitial lung diseases”, J. Am. Chem. Soc. 138, 8392-8395(2016)